These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 38016356)

  • 1. Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy.
    Bagheri M; Zandieh MA; Daryab M; Samaei SS; Gholami S; Rahmanian P; Dezfulian S; Eary M; Rezaee A; Rajabi R; Khorrami R; Salimimoghadam S; Hu P; Rashidi M; Ardakan AK; Ertas YN; Hushmandi K
    Transl Oncol; 2024 Jan; 39():101838. PubMed ID: 38016356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer.
    Huang CZ; Zhou Y; Tong QS; Duan QJ; Zhang Q; Du JZ; Yao XQ
    Biomaterials; 2022 Nov; 290():121827. PubMed ID: 36228517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy.
    Zandieh MA; Farahani MH; Daryab M; Motahari A; Gholami S; Salmani F; Karimi F; Samaei SS; Rezaee A; Rahmanian P; Khorrami R; Salimimoghadam S; Nabavi N; Zou R; Sethi G; Rashidi M; Hushmandi K
    Biomed Pharmacother; 2023 Oct; 166():115283. PubMed ID: 37567073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy.
    Ashrafizadeh M; Zarrabi A; Bigham A; Taheriazam A; Saghari Y; Mirzaei S; Hashemi M; Hushmandi K; Karimi-Maleh H; Nazarzadeh Zare E; Sharifi E; Ertas YN; Rabiee N; Sethi G; Shen M
    Med Res Rev; 2023 Nov; 43(6):2115-2176. PubMed ID: 37165896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer.
    Lo YL; Lin HC; Tseng WH
    Acta Biomater; 2022 Nov; 153():465-480. PubMed ID: 36115656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application.
    Karimi K; Mojtabavi S; Tehrany PM; Nejad MM; Rezaee A; Mohtashamian S; Hamedi E; Yousefi F; Salmani F; Zandieh MA; Nabavi N; Rabiee N; Ertas YN; Salimimoghadam S; Rashidi M; Rahmanian P; Hushmandi K; Yu W
    Int J Biol Macromol; 2023 Jul; 242(Pt 3):124935. PubMed ID: 37230442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.
    Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L
    Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches.
    Ashrafizadeh M; Delfi M; Zarrabi A; Bigham A; Sharifi E; Rabiee N; Paiva-Santos AC; Kumar AP; Tan SC; Hushmandi K; Ren J; Zare EN; Makvandi P
    J Control Release; 2022 Nov; 351():50-80. PubMed ID: 35934254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: A promising approach in cancer chemotherapy.
    Zou J
    Environ Res; 2023 Dec; 238(Pt 1):117111. PubMed ID: 37734579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin and Gedatolisib (PKI-587) Co-Loaded Hollow Polydopamine Nano-Shells with Simultaneous Upstream and Downstream Action to Re-Sensitize Drugs-Resistant Hepatocellular Carcinoma to Chemotherapy.
    Zhang YC; Wu CG; Li AM; Liang Y; Ma D; Tang XL
    J Biomed Nanotechnol; 2021 Jan; 17(1):18-36. PubMed ID: 33653494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers.
    Entezari M; Yousef Abad GG; Sedghi B; Ettehadi R; Asadi S; Beiranvand R; Haratian N; Karimian SS; Jebali A; Khorrami R; Zandieh MA; Saebfar H; Hushmandi K; Salimimoghadam S; Rashidi M; Taheriazam A; Hashemi M; Ertas YN
    Environ Res; 2023 May; 225():115673. PubMed ID: 36906270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer.
    Hashemi M; Esbati N; Rashidi M; Gholami S; Raesi R; Bidoki SS; Goharrizi MASB; Motlagh YSM; Khorrami R; Tavakolpournegari A; Nabavi N; Zou R; Mohammadnahal L; Entezari M; Taheriazam A; Hushmandi K
    Transl Oncol; 2024 Feb; 40():101846. PubMed ID: 38042134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo Evaluation of a Novel Estrogen-Targeted PEGylated Oxaliplatin Liposome for Gastric Cancer.
    Sun Y; Xie Y; Tang H; Ren Z; Luan X; Zhang Y; Zhu M; Lv Z; Bao H; Li Y; Liu R; Shen Y; Zheng Y; Pei J
    Int J Nanomedicine; 2021; 16():8279-8303. PubMed ID: 34992365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (Nano)biotechnological approaches in the treatment of cervical cancer: integration of engineering and biology.
    Xie W; Xu Z
    Front Immunol; 2024; 15():1461894. PubMed ID: 39346915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer.
    Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J
    Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-empowered nanotheranostics in breast and lung cancers therapy.
    Alsaikhan F
    Environ Res; 2023 Nov; 237(Pt 1):116951. PubMed ID: 37633628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel.
    Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G
    Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser-Induced Combinatorial Chemotherapeutic, Chemodynamic, and Photothermal Therapy for Hepatocellular Carcinoma Based on Oxaliplatin-Loaded Metal-Organic Frameworks.
    Huang R; Liu W; Zhang Q; Zhu G; Qu W; Tao C; Gao J; Fang Y; Fu X; Zhou J; Shi Y; Fan J; Tang Z
    ACS Appl Mater Interfaces; 2023 Jan; 15(3):3781-3790. PubMed ID: 36631295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody Conjugated PLGA Nanocarriers and Superparmagnetic Nanoparticles for Targeted Delivery of Oxaliplatin to Cells from Colorectal Carcinoma.
    Zumaya ALV; Rimpelová S; Štějdířová M; Ulbrich P; Vilčáková J; Hassouna F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
    Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.